RxDoctor Payments Data

Kabita Nanda

Pediatric Rheumatology · Seattle, WANPI 1780818518

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,550 of the $5,742 with a category attached, or 79.2%. Pfizer accounts for 74.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $3,300 and has fallen 94.8% since, to $173 in 2025.

$5,742in general payments, 2019–2025

Across 7 payments — averaging $820.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • Azurity Pharmaceuticals, Inc.$1K
  • Sobi, Inc$242
$878,671in research payments, 2019–2025

Across 90 payments — averaging $9763.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$467K
  • AbbVie$241K
  • Pfizer$100K
  • Genentech, Inc.$70K

What the payments were for

  • Consulting fees$4,55079%
  • Speaking & faculty fees$95017%
  • Food & beverage$691%
  • Education$1733%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer3$4,250
Azurity Pharmaceuticals, Inc.1$1,250
Sobi, Inc3$242

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric rheumatology providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Other pediatric rheumatology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →